Sex | Age [months] | wt St | wt HF | Tau22 St | Tau22 HF | |
---|---|---|---|---|---|---|
Fasting insulin [ng/ml] | Male (n = 7–8) | 7 | 0.18±0.02 | 1.07±0.43** | 0.15±0.03 | 1.17±0.32*** |
Male (n = 7–12) | 11 | 0.40±0.11$ | 7.80±3.96**, $ | 0.15±0.05 | 2.43±0.85*** | |
Female (n = 7–8) | 7 | 0.17±0.03 | 0.57±0.14** | 0.12±0.03 | 0.35±0.06** | |
Female (n = 6–7) | 11 | 0.15±0.07 | 1.87±0.82** | 0.22±0.06 | 3.58±1.57**, $$ | |
HOMA-IR | Male (n = 7–8) | 7 | 12.45±1.65 | 89.43±36.83*** | 10.81±2.83 | 102.47±32.20** |
Male (n = 7–12) | 11 | 23.66±6.00 | 475.67±210.86**, $ | 8.53±2.85 | 150.95±47.97*** | |
Female (n = 7–8) | 7 | 10.22±2.37 | 41.69±9.68** | 7.36±1.86 | 26.52±4.33** | |
Female (n = 6–7) | 11 | 9.08±4.12 | 83.87±32.06** | 14.16±4.31 | 229.88±106.68**, $$ | |
QUICKI | Male (n = 7–8) | 7 | 0.35±0.01 | 0.29±0.01*** | 0.38±0.02 | 0.28±0.01** |
Male (n = 7–12) | 11 | 0.35±0.02 | 0.25±0.01** | 0.39±0.01 | 0.27±0.01*** | |
Female (n = 7–8) | 7 | 0.37±0.01 | 0.31±0.01** | 0.40±0.02 | 0.32±0.01** | |
Female (n = 6–7) | 11 | 0.55±0.12$ | 0.29±0.01** | 0.36±0.02 | 0.25±0.02** |